Docor International Management
VC Fund
Tel Aviv, Israel
Docor International Management is a VC fund in Tel Aviv focused on Health Care and Biotechnology. Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Docor International Management invests in
Stages Docor International Management invests in
Countries Docor International Management invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Series C
- $13M–$22M
- Venture - Series Unknown
- $8M–$15M
Investment Focus
Industry
- Health Care 9 (50%)
- Biotechnology 8 (44%)
- Medical Device 4 (22%)
- Medical 3 (17%)
- 3D Technology 3 (17%)
Stage
- Funding Round 4 (22%)
- Series C 3 (17%)
- Venture - Series Unknown 2 (11%)
- Series A 1 (6%)
- Series B 1 (6%)
Country
- Israel 12 (67%)
- United States 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Adi Goldin
Director of business development
|
Director of business development | Total investments: 2 | Find email | |
Anat Klein
Member
|
Member | Total investments: 0 | Find email | |
Andre Betting
Foundation Executive Director
|
Foundation Executive Director | Total investments: 0 | Find email | |
Gideon Frank
Member
|
Member | Total investments: 0 | Find email | |
Rien Van Gendt
Member
|
Member | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management. | $22M / Series C / Dec 18, 2019 | ||
| Raziel's drug aims for fat melting by harnessing the body’s own natural healing power and delivering proven biological activity. | $22M / Series C / Dec 03, 2019 | ||
| SP Nano is a nanotechnology company commercializing the use of nano-particles in the rapidly growing $106 billion composites market. The most widely-used type of composite consists of layers of fabric (carbon-fiber, glass-fiber, aramid) held together by a resin matrix. The matrix is the materials' weakest link - much weaker than the layersof fibers it binds. When composite structures and components commonly used in the aerospace, defense, automotive, marine and sporting goods industries fail, it's often because of this large discrepancy in strength between the fibers and the resin. | $2.5M / Corporate Round / Oct 12, 2017 | ||
| Colospan is a clinical-stage medical device company developing proprietary technology for colorectal surgery to prevent anastomotic leaks and diverting colonic stomas. It has developed a product that protects the intestine after a colectomy and sealing of the intestine, which is performed in cases of severe intestinal inflammatory disease andcancer of the bowel or rectum. In places where the intestine has been sealed, leakage requiring prolonged hospitalization or repeat surgery on already weak patients is liable to occur. The company develops a device that prevents inner-body leaks after intestinal surgery. It also develops a silicone-based, tube-like device intended to prevent the leak of feces into the body cavity after surgery in the intestines or colon. Colospan's device is meant to prevent or delay the for need colostomy—the surgical creation of an external bypass for the intestine or colon following the removal of a diseased part. The company’s lead product is a single-use, temporary intraluminal bypass device designed to reduce contact between fecal matter and the anastomotic site.Colospan was founded in 2010 and is based in Kefar Sava, Israel. | $8M / Venture - Series Unknown / Oct 01, 2017 | ||
| OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility. | $15M / Venture - Series Unknown / Jan 29, 2016 | ||
| SP Nano is a nanotechnology company commercializing the use of nano-particles in the rapidly growing $106 billion composites market. The most widely-used type of composite consists of layers of fabric (carbon-fiber, glass-fiber, aramid) held together by a resin matrix. The matrix is the materials' weakest link - much weaker than the layersof fibers it binds. When composite structures and components commonly used in the aerospace, defense, automotive, marine and sporting goods industries fail, it's often because of this large discrepancy in strength between the fibers and the resin. | $1.2M / Convertible Note / Jun 01, 2015 | ||
| Check-Cap is a young and dynamic medical device company with breakthrough solution for Colorectal Cancer Screening. The Check-Cap device requires no bowel preparation or invasive procedures, and is expected to detect clinically significant polyps within the same range of accuracy as a standard colonoscopy. | $12M / Debt Financing / Oct 19, 2014 | ||
| SP Nano is a nanotechnology company commercializing the use of nano-particles in the rapidly growing $106 billion composites market. The most widely-used type of composite consists of layers of fabric (carbon-fiber, glass-fiber, aramid) held together by a resin matrix. The matrix is the materials' weakest link - much weaker than the layersof fibers it binds. When composite structures and components commonly used in the aerospace, defense, automotive, marine and sporting goods industries fail, it's often because of this large discrepancy in strength between the fibers and the resin. | $2M / Series B / Jun 20, 2014 | ||
| EarlySense develops signal-processing technology. The company's lead product, EverOn, a contact-free early detection patient supervision system that measures, records, displays, and alerts heart and respiration rates, as well as bed entries and exits, patient motion, and quality of sleep from under the mattress. EarlySense Ltd. was founded in2004 and is based in Ramat Gan, Israel with a research and development facility in Israel; and marketing offices in Boston, Massachusetts. | $15M / Series E / Nov 12, 2012 | ||
| SP Nano is a nanotechnology company commercializing the use of nano-particles in the rapidly growing $106 billion composites market. The most widely-used type of composite consists of layers of fabric (carbon-fiber, glass-fiber, aramid) held together by a resin matrix. The matrix is the materials' weakest link - much weaker than the layersof fibers it binds. When composite structures and components commonly used in the aerospace, defense, automotive, marine and sporting goods industries fail, it's often because of this large discrepancy in strength between the fibers and the resin. | $3.3M / Series A / Jun 01, 2012 | ||
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Docor International Management invest in?
Docor International Management invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Funding Round and Series C stage. Most of the 18 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Docor International Management's check size?
Docor International Management typically joins rounds of $13M–$22M at Series C and $8M–$15M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Docor International Management participates in.
How do I contact Docor International Management?
Public channels for Docor International Management include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Docor International Management?
The team at Docor International Management includes Adi Goldin (Director of business development), Anat Klein (Member) and Andre Betting (Foundation Executive Director), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
